BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31075507)

  • 1. CYP24A1 genetic variants in the vitamin D metabolic pathway are involved in the outcomes of hepatitis C virus infection among high-risk Chinese population.
    Fan HZ; Zhang R; Tian T; Zhong YL; Wu MP; Xie CN; Yang JJ; Huang P; Yu RB; Zhang Y; Wang J
    Int J Infect Dis; 2019 Jul; 84():80-88. PubMed ID: 31075507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variant of RXR involved in the vitamin D metabolic pathway was linked to HCV infection outcomes among a high-risk Chinese population.
    Zhang R; Fu Z; Fan H; Tian T; Wu M; Xie C; Huang P; Yu R; Zhang Y; Zhang W; Wang J
    Infect Genet Evol; 2021 Jan; 87():104641. PubMed ID: 33246082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CYP2R1, CYP27A1 and CYP27B1 genetic polymorphisms controlling vitamin D metabolism on susceptibility to hepatitis C virus infection in a high-risk Chinese population.
    Yang JJ; Fan HZ; Tian T; Wu MP; Xie CN; Huang P; Yu RB; Yi HG; Zhang Y; Wang J
    Arch Virol; 2019 Dec; 164(12):2909-2918. PubMed ID: 31520221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D level and vitamin D receptor genetic variations contribute to HCV infection susceptibility and chronicity in a Chinese population.
    Wu M; Yue M; Huang P; Zhang Y; Xie C; Yu R; Li J; Wang J
    Infect Genet Evol; 2016 Jul; 41():146-152. PubMed ID: 27063396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk.
    Reimers LL; Crew KD; Bradshaw PT; Santella RM; Steck SE; Sirosh I; Terry MB; Hershman DL; Shane E; Cremers S; Dworakowski E; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Causes Control; 2015 Feb; 26(2):187-203. PubMed ID: 25421379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
    Wu X; Cheng J; Yang K
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.
    Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A
    Cancer Chemother Pharmacol; 2018 Mar; 81(3):615-620. PubMed ID: 29356898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
    Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
    BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association study between CYP24A1 gene polymorphisms and cancer risk.
    Yi C; Huang C; Wang H; Wang C; Dong L; Gu X; Feng X; Chen B
    Pathol Res Pract; 2020 Jan; 216(1):152735. PubMed ID: 31740231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Promoter Polymorphism of the Vitamin D Metabolism Gene Cyp24a1 is Associated with Severe Atopic Dermatitis in Adults.
    Hallau J; Hamann L; Schumann RR; Worm M; Heine G
    Acta Derm Venereol; 2016 Feb; 96(2):169-72. PubMed ID: 26315479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients.
    Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A
    Infect Genet Evol; 2018 Jun; 60():42-47. PubMed ID: 29452294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association study between CYP24A1 gene polymorphisms and risk of liver, lung and gastric cancer in a Chinese population.
    Xiong Q; Jiao Y; Yang P; Liao Y; Gu X; Hu F; Chen B
    Pathol Res Pract; 2020 Dec; 216(12):153237. PubMed ID: 33065483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.
    Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A
    Antivir Ther; 2015; 20(3):335-41. PubMed ID: 25279449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of
    Fam MS; Hassanein SI; Abdel Rahman MF; Assal RA; Hanafi RS; Gad MZ
    Can J Physiol Pharmacol; 2019 Dec; 97(12):1152-1158. PubMed ID: 31398293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D binding protein polymorphisms influence susceptibility to hepatitis C virus infection in a high-risk Chinese population.
    Xie CN; Yue M; Huang P; Tian T; Fan HZ; Wu MP; Yu RB; Yi HG; Xia XS; Feng Y; Zhang Y; Wang J
    Gene; 2018 Dec; 679():405-411. PubMed ID: 30218750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of vitamin D receptor (VDR), CYP27B1 and CYP24A1 genes and the risk of colorectal cancer.
    Vidigal VM; Silva TD; de Oliveira J; Pimenta CAM; Felipe AV; Forones NM
    Int J Biol Markers; 2017 May; 32(2):e224-e230. PubMed ID: 28009432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.
    Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A
    Pharmacogenet Genomics; 2016 Jun; 26(6):307-10. PubMed ID: 27139837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of vitamin D metabolism genes and serum level of vitamin D in colorectal cancer.
    Marques Vidigal V; Aguiar Junior PN; Donizetti Silva T; de Oliveira J; Marques Pimenta CA; Vitor Felipe A; Manoukian Forones N
    Int J Biol Markers; 2017 Oct; 32(4):e441-e446. PubMed ID: 28665452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of CYP24A1 variants in coronary heart disease among the Chinese population.
    Qian P; Cao X; Xu X; Duan M; Zhang Q; Huang G
    Lipids Health Dis; 2020 Aug; 19(1):181. PubMed ID: 32762692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.